Corbus Pharmaceuticals Holdings, Inc.
CRBPNext catalyst
CRB-701
Solid Tumor, Adult
Get an email about CRBP's next catalysts
Track Corbus Pharmaceuticals Holdings (CRBP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (earnings).See the timeline
2 upcoming, 1 past
CRBP Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-1.45 | FQ end Sep/2026 | Call: tbd
CRB-701 Phase 2 Est. Readout
Primary completion for CRB-701 trial (NCT06265727) in Solid Tumor, Adult
SourceMarket Overview
Stock performance and key metrics
CRB-701
Solid Tumor, Adult
Lenabasum
Cystic Fibrosis
capcitabine
Oropharyngeal Carcinoma (OPC)
Anti-PD-1 monoclonal antibody
Solid Tumor
JBT-101 (lenabasum)
Cystic Fibrosis
Anti-PD-1
Solid Tumor, Adult
CRB-601 monoclonal antibody
Solid Tumor
JBT-101
Systemic Lupus Erythematosus
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CRB-701 | Phase 3 | Solid Tumor, Adult | - | - |
Lenabasum | Phase 3 | Cystic Fibrosis | - | - |
capcitabine | Phase 3 | Oropharyngeal Carcinoma (OPC) | - | - |
Anti-PD-1 monoclonal antibody | Phase 2 | Solid Tumor | - | - |
JBT-101 (lenabasum) | Phase 2 | Cystic Fibrosis | - | - |
Anti-PD-1 | Phase 2 | Solid Tumor, Adult | - | - |
CRB-601 monoclonal antibody | Phase 2 | Solid Tumor | - | - |
JBT-101 | Phase 2 | Systemic Lupus Erythematosus | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Corbus Pharmaceuticals Holdings, Inc.'s drug pipeline?→
CatalystAlert tracks 8 drug candidates in Corbus Pharmaceuticals Holdings, Inc.'s (CRBP) pipeline across Phase 3, Phase 2. Its lead program is CRB-701 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Corbus Pharmaceuticals Holdings, Inc.'s next FDA catalyst?→
Corbus Pharmaceuticals Holdings, Inc.'s (CRBP) next tracked catalyst is a Phase 2 readout expected January 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CRBP biotech catalysts?→
Add CRBP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Corbus Pharmaceuticals Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.